# A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles

> **NCT03945513** · PHASE3 · COMPLETED · sponsor: **Insud Pharma** · enrollment: 1034 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** LPRI424 (dienogest/ethinylestradiol)

## Key facts

- **NCT ID:** NCT03945513
- **Lead sponsor:** Insud Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-03
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-09-08
- **Target enrollment:** 1034 (ACTUAL)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945513, "A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03945513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*